Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.44 is 252% below its 5-year average of -0.12, near the low end of its 5-year range (-0.44–0.09).
934.08% below its 12-month average of -0.04.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.36.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 10 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T11:56:08.636Z. Historical observations retain their original dates. Historical series through 2026-02-26.
EARNINGS PER SHARE (EPS)
-0.44
EARNINGS PER SHARE (EPS) AVG TTM
-0.04
EARNINGS PER SHARE (EPS) AVG 3Y
-0.09
EARNINGS PER SHARE (EPS) AVG 5Y
-0.12
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-934.08%
CURRENT VS 3Y AVG
-415.83%
CURRENT VS 5Y AVG
-252.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Certara, Inc.
Market Cap
$1.57B
Earnings Per Share (EPS)
-0.44
TTM Avg
-0.04
3Y Avg
-0.09
5Y Avg
-0.12
Market Cap
$1.52B
Earnings Per Share (EPS)
0.38
TTM Avg
-0.16
3Y Avg
-0.18
5Y Avg
-0.35
Market Cap
$1.51B
Earnings Per Share (EPS)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.65B
Earnings Per Share (EPS)
-0.72
TTM Avg
-1.04
3Y Avg
-1.27
5Y Avg
-1.30
Market Cap
$1.65B
Earnings Per Share (EPS)
4.63
TTM Avg
1.23
3Y Avg
0.09
5Y Avg
-0.82
Market Cap
$1.46B
Earnings Per Share (EPS)
5.37
TTM Avg
-2.79
3Y Avg
-4.06
5Y Avg
-3.18
Market Cap
$1.43B
Earnings Per Share (EPS)
N/A
TTM Avg
-2.33
3Y Avg
-2.33
5Y Avg
-2.33
Market Cap
$1.71B
Earnings Per Share (EPS)
-2.74
TTM Avg
-3.74
3Y Avg
-3.13
5Y Avg
-1.84
Market Cap
$1.76B
Earnings Per Share (EPS)
0.19
TTM Avg
-0.34
3Y Avg
-0.57
5Y Avg
-0.59
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.57B | -0.44 | -0.04 | -0.09 | -0.12 |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.52B | 0.38 | -0.16 | -0.18 | -0.35 |
| Braveheart Bio, Inc. (BRVE)vs › | $1.51B | N/A | N/A | N/A | N/A |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | -0.72 | -1.04 | -1.27 | -1.30 |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 4.63 | 1.23 | 0.09 | -0.82 |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 5.37 | -2.79 | -4.06 | -3.18 |
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG)vs › | $1.43B | N/A | -2.33 | -2.33 | -2.33 |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | -2.74 | -3.74 | -3.13 | -1.84 |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 0.19 | -0.34 | -0.57 | -0.59 |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | -3.36 | -4.53 | -5.16 | -4.47 |
Trailing EPS (TTM)
$-0.44
Forward EPS (Est.)
$0.34
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.01 |
| 2024-12-31 | -0.08 |
| 2023-12-31 | -0.35 |
| 2022-12-31 | 0.09 |
| 2021-12-31 | -0.09 |
| 2020-12-31 | -0.32 |
| 2019-12-31 | -0.06 |
| 2018-12-31 | -0.25 |
